Logo image of CRGE

CHARGE ENTERPRISES INC (CRGE) Stock Fundamental Analysis

NASDAQ:CRGE - US1596101048 - Common Stock

0.0288 USD
-0.03 (-52%)
Last: 2/28/2024, 8:27:57 PM
0.0278 USD
0 (-3.47%)
After Hours: 2/28/2024, 8:27:57 PM
Fundamental Rating

2

Taking everything into account, CRGE scores 2 out of 10 in our fundamental rating. CRGE was compared to 34 industry peers in the Diversified Telecommunication Services industry. The financial health of CRGE is average, but there are quite some concerns on its profitability. CRGE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CRGE has reported negative net income.
CRGE had a positive operating cash flow in the past year.
CRGE had negative earnings in each of the past 5 years.
In the past 5 years CRGE always reported negative operating cash flow.
CRGE Yearly Net Income VS EBIT VS OCF VS FCFCRGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

CRGE has a worse Return On Assets (-22.08%) than 89.19% of its industry peers.
CRGE has a Return On Equity of -95.02%. This is amonst the worse of the industry: CRGE underperforms 89.19% of its industry peers.
Industry RankSector Rank
ROA -22.08%
ROE -95.02%
ROIC N/A
ROA(3y)-38.85%
ROA(5y)N/A
ROE(3y)-199.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRGE Yearly ROA, ROE, ROICCRGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -100 -200

1.3 Margins

CRGE's Gross Margin of 4.84% is on the low side compared to the rest of the industry. CRGE is outperformed by 94.59% of its industry peers.
The Profit Margin and Operating Margin are not available for CRGE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRGE Yearly Profit, Operating, Gross MarginsCRGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -10 -20 -30 -40

4

2. Health

2.1 Basic Checks

CRGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRGE has more shares outstanding
Compared to 1 year ago, CRGE has an improved debt to assets ratio.
CRGE Yearly Shares OutstandingCRGE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 50M 100M 150M 200M
CRGE Yearly Total Debt VS Total AssetsCRGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

CRGE has an Altman-Z score of 1.36. This is a bad value and indicates that CRGE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CRGE (1.36) is better than 81.08% of its industry peers.
The Debt to FCF ratio of CRGE is 1.50, which is an excellent value as it means it would take CRGE, only 1.50 years of fcf income to pay off all of its debts.
CRGE has a better Debt to FCF ratio (1.50) than 91.89% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that CRGE is somewhat dependend on debt financing.
CRGE's Debt to Equity ratio of 0.63 is fine compared to the rest of the industry. CRGE outperforms 70.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 1.5
Altman-Z 1.36
ROIC/WACCN/A
WACC8.03%
CRGE Yearly LT Debt VS Equity VS FCFCRGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 10M -10M 20M 30M 40M

2.3 Liquidity

CRGE has a Current Ratio of 0.94. This is a bad value and indicates that CRGE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CRGE (0.94) is comparable to the rest of the industry.
CRGE has a Quick Ratio of 0.94. This is a bad value and indicates that CRGE is not financially healthy enough and could expect problems in meeting its short term obligations.
CRGE has a Quick ratio (0.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.93
CRGE Yearly Current Assets VS Current LiabilitesCRGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.05% over the past year.
CRGE shows a decrease in Revenue. In the last year, the revenue decreased by -1.21%.
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-1.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-28.85%

3.2 Future

The Earnings Per Share is expected to grow by 16.96% on average over the next years. This is quite good.
CRGE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.49% yearly.
EPS Next Y48.57%
EPS Next 2Y33.1%
EPS Next 3Y16.96%
EPS Next 5YN/A
Revenue Next Year-15.65%
Revenue Next 2Y-5.97%
Revenue Next 3Y-2.49%
Revenue Next 5YN/A

3.3 Evolution

CRGE Yearly Revenue VS EstimatesCRGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 200M 400M 600M
CRGE Yearly EPS VS EstimatesCRGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -0.1 -0.2 -0.3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRGE. In the last year negative earnings were reported.
Also next year CRGE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRGE Price Earnings VS Forward Price EarningsCRGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CRGE is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.33
EV/EBITDA N/A
CRGE Per share dataCRGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

CRGE's earnings are expected to grow with 16.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.1%
EPS Next 3Y16.96%

0

5. Dividend

5.1 Amount

CRGE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHARGE ENTERPRISES INC

NASDAQ:CRGE (2/28/2024, 8:27:57 PM)

After market: 0.0278 0 (-3.47%)

0.0288

-0.03 (-52%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)11-08 2023-11-08/bmo
Earnings (Next)03-26 2024-03-26/amc
Inst Owners0.02%
Inst Owner Change0%
Ins Owners15.25%
Ins Owner Change0%
Market Cap6.19M
Analysts43.33
Price Target3.83 (13198.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-3.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.93%
Min EPS beat(2)18.3%
Max EPS beat(2)21.57%
EPS beat(4)3
Avg EPS beat(4)2.35%
Min EPS beat(4)-60.43%
Max EPS beat(4)29.97%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.26%
Min Revenue beat(2)-20.72%
Max Revenue beat(2)-9.8%
Revenue beat(4)1
Avg Revenue beat(4)-10.76%
Min Revenue beat(4)-20.72%
Max Revenue beat(4)0.96%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.33
P/OCF 0.33
P/B 0.14
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.09
FCFY300.27%
OCF(TTM)0.09
OCFY303.22%
SpS2.98
BVpS0.2
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.08%
ROE -95.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.84%
FCFM 2.9%
ROA(3y)-38.85%
ROA(5y)N/A
ROE(3y)-199.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover3.42
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 1.5
Debt/EBITDA N/A
Cap/Depr 2.23%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.93
Altman-Z 1.36
F-Score5
WACC8.03%
ROIC/WACCN/A
Cap/Depr(3y)170.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y48.57%
EPS Next 2Y33.1%
EPS Next 3Y16.96%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-28.85%
Revenue Next Year-15.65%
Revenue Next 2Y-5.97%
Revenue Next 3Y-2.49%
Revenue Next 5YN/A
EBIT growth 1Y11.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.53%
EBIT Next 3Y27.17%
EBIT Next 5YN/A
FCF growth 1Y575.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y869.63%
OCF growth 3YN/A
OCF growth 5YN/A